Webinar Date and Time: Wednesday, November 23, 2022 4:00 – 5:00 pm EST
In the second educational webinar, Dr. Michael Crump from Princess Margaret Hospital will cover what bispecific antibodies are and how this novel therapy can help lymphoma patients across Canada. This talk will highlight who is eligible for bispecific antibody therapy and the clinical trials available for lymphoma patients in Canada.
Speakers: Dr. Mark Bosch
Speaker Biographies:
Dr. Mark Bosch
Dr. Mark Bosch is a stem cell transplant physician at the Saskatoon Cancer Centre. He completed his medical school and internal medicine at the University of Saskatchewan. He completed his sub-specialty in Hematology and Bone Marrow Transplant at the University of Calgary. Dr. Bosch is very active in administration, teaching, and clinical research in leukemia, lymphoma, CAR T and bone marrow transplantation.
